The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
Kägi, D., Ledermann, B., Bürki, K., Seiler, P., Odermatt, B., Olsen, K. J., Podack, E. R., Zinkernagel, R. M., & Hengartner, H. (1994) · Nature · doi:10.1038/369031a0 · Cited by 1,757
Townsend, A. (1986) · Cell · doi:10.1016/0092-8674(86)90019-x · Cited by 1,699
The Concept of Immunological Surveillance
Burnet, F. M. (2015) · Progress in Tumor Research · doi:10.1159/000386035 · Cited by 1,656
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465 · cited 3×
“Similar results were obtained in mice that lacked either the receptor for IFN-c or one of the proteins required for IFN-receptor function (Stat1) [ 32 ].”
BackgroundResultInfluentialImmunity to Methylcholanthrene-Induced Sarcomas
(1957) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/18.6.769 · Cited by 1,229
Tumor Antigens Recognized by T Lymphocytes
Boon, T., Cerottini, J.-C., Van den Eynde, B., van der Bruggen, P., & Van Pel, A. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.002005 · Cited by 1,221
Recognition of Stress-Induced MHC Molecules by Intestinal Epithelial γδ T Cells
Groh, V., Steinle, A., Bauer, S., & Spies, T. (1998) · Science · doi:10.1126/science.279.5357.1737 · Cited by 1,142
Regulation of Cutaneous Malignancy by γδ T Cells
Girardi, M., Oppenheim, D. E., Steele, C. R., Lewis, J. M., Glusac, E., Filler, R., Hobby, P., Sutton, B., Tigelaar, R. E., & Hayday, A. C. (2001) · Science · doi:10.1126/science.1063916 · Cited by 1,004
Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells
Groh, V., Rhinehart, R., Randolph-Habecker, J., Topp, M. S., Riddell, S. R., & Spies, T. (2001) · Nature Immunology · doi:10.1038/85321 · Cited by 951
RECEPTORS FOR HLA CLASS-I MOLECULES IN HUMAN NATURAL KILLER CELLS
Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M. C., & Moretta, L. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.619 · Cited by 875
Implications for immunosurveillance of altered HLA class I phenotypes in human tumours
Garrido, F., Ruiz-Cabello, F., Cabrera, T., Pérez-Villar, J. J., López-Botet, M., Duggan-Keen, M., & Stern, P. L. (1997) · Immunology Today · doi:10.1016/s0167-5699(96)10075-x · Cited by 770
Self-citationDoes the Immune System See Tumors as Foreign or Self?
Pardoll, D. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141135 · Cited by 753
A listing of human tumor antigens recognized by T cells
Renkvist, N., Castelli, C., Robbins, P. F., & Parmiani, G. (2001) · Cancer Immunology, Immunotherapy · doi:10.1007/s002620000169 · Cited by 694
Tomasec, P., Braud, V. M., Rickards, C., Powell, M. B., McSharry, B. P., Gadola, S., Cerundolo, V., Borysiewicz, L. K., McMichael, A. J., & Wilkinson, G. W. G. (2000) · Science · doi:10.1126/science.287.5455.1031 · Cited by 661
Van den Eynde, B. J., & van der Bruggen, P. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80050-7 · Cited by 623
Perforin-Mediated Cytotoxicity Is Critical for Surveillance of Spontaneous Lymphoma
Smyth, M. J., Thia, K. Y. T., Street, S. E. A., MacGregor, D., Godfrey, D. I., & Trapani, J. A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.755 · Cited by 576
Perforin and interferon-γ activities independently control tumor initiation, growth, and metastasis
Street, S. E. A., Cretney, E., & Smyth, M. J. (2001) · Blood · doi:10.1182/blood.v97.1.192 · Cited by 572
Braud, V., Yvonne Jones, E., & McMichael, A. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270517 · Cited by 502
MHC class I antigens, immune surveillance, and tumor immune escape
Garcia‐Lora, A., Algarra, I., & Garrido, F. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10290 · Cited by 501
Self-citationγδ T Cells Provide an Early Source of Interferon γ in Tumor Immunity
Gao, Y., Yang, W., Pan, M., Scully, E., Girardi, M., Augenlicht, L. H., Craft, J., & Yin, Z. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030584 · Cited by 453
Natural history of HLA expression during tumour development
Garrido, F., Cabrera, T., Concha, A., Glew, S., Ruiz-Cabello, F., & Stern, P. L. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90264-l · Cited by 448
Self-citationHLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance
Paul, P., Rouas-Freiss, N., Khalil-Daher, I., Moreau, P., Riteau, B., Le Gal, F. A., Avril, M. F., Dausset, J., Guillet, J. G., & Carosella, E. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4510 · Cited by 432
Tumor progression and metastasis
Yokota, J. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.497 · Cited by 426
Llano, M., Lee, N., Navarro, F., García, P., Albar, J. P., Geraghty, D. E., & López-Botet, M. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199809)28:09<2854::aid-immu2854>3.0.co;2-w · Cited by 382
NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma
Smyth, M. J., Crowe, N. Y., & Godfrey, D. I. (2001) · International Immunology · doi:10.1093/intimm/13.4.459 · Cited by 379
NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma
Smyth, M. J. (2008) · International Immunology · doi:10.1093/intimm/dxn028 · Cited by 377
MHC antigens and tumor escape from immune surveillance
(2001) · Advances in Cancer Research · doi:10.1016/s0065-230x(01)83005-0 · Cited by 305
Jäger, E., Ringhoffer, M., Karbach, J., Arand, M., Oesch, F., & Knuth, A. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960516)66:4<470::aid-ijc10>3.0.co;2-c · Cited by 278
HLA class I antigen abnormalities and immune escape by malignant cells
Seliger, B., Cabrera, T., Garrido, F., & Ferrone, S. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0404 · Cited by 270
Self-citationLehmann, F., Marchand, M., Hainaut, P., Pouillart, P., Sastre, X., Ikeda, H., Boon, T., & Coulie, P. G. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250206 · Cited by 225
Girardi, M., Glusac, E., Filler, R. B., Roberts, S. J., Propperova, I., Lewis, J., Tigelaar, R. E., & Hayday, A. C. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021282 · Cited by 185
Analysis of HLA-E expression in human tumors
Marín, R., Ruiz-Cabello, F., Pedrinaci, S., Méndez, R., Jiménez, P., Geraghty, D. E., & Garrido, F. (2003) · Immunogenetics · doi:10.1007/s00251-002-0526-9 · Cited by 178
Self-citationJohnsen, A. K., Templeton, D. J., Sy, M.-S., & Harding, C. V. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4224 · Cited by 173
Perforin dependence of natural killer cell‐mediated tumor control in vivo
van den Broek, M. F., Kägi, D., Zinkernagel, R. M., & Hengartner, H. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251246 · Cited by 171
Skin cancer in liver transplant recipients
Otley, C. C., & Pittelkow, M. R. (2000) · Liver Transplantation · doi:10.1053/lv.2000.6352 · Cited by 129
Stutman, O. (1979) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/62.2.353 · Cited by 106
ENGEL, A. ‐., Svane, I. M., Rygaard, J., & Werdelin, O. (1997) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1997.d01-419.x · Cited by 101
Development of spontaneous uterine tumors in low molecular mass polypeptide-2 knockout mice.
Hayashi, T., & Faustman, D. L. (2002) · PubMed · Cited by 97
Garcia-Lora, A. M., Martinez, M., Algarra, I., Gaforio, J. J., & Garrido, F. (2003) · International Journal of Cancer · doi:10.1002/ijc.11241 · Cited by 92
Self-citationBauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. A. (2018) · The Journal of Immunology · doi:10.1093/jimmunol/200.7.2231 · Cited by 87
Immunoselection by T lymphocytes generates repeated MHC class I-deficient metastatic tumor variants
Garcia-Lora, A. M., Algarra, I., Gaforio, J. J., Ruiz‐Cabello, F., & Garrido, F. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20010101)91:1<109::aid-ijc1017>3.0.co;2-e · Cited by 85
Self-citationSvane, I. M., Engel, A., Nielsen, M.-B., et al. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260827 · Cited by 79
Pillars Article: Regulation of Cutaneous Malignancy by γδ T Cells. Science. 2001. 294: 605–609
Girardi, M., Oppenheim, D. E., Steele, C. R., Lewis, J. M., Glusac, E. J., Filler, R. B., Hobby, P., Sutton, B. J., Tigelaar, R. E., & Hayday, A. (2018) · The Journal of Immunology · doi:10.1093/jimmunol/200.9.3031 · Cited by 64
Immunosuppressive Factors: Role in Cancer Development and Progression
Botti, C., Seregni, E. C., Ferrari, L., Martinetti, A., & Bombardieri, E. (1998) · The International Journal of Biological Markers · doi:10.1177/172460089801300201 · Cited by 63
Spontaneous and induced primary oncogenesis in natural killer (nk)‐cell‐deficient beige mutant mice
Haliotis, T. P., Ball, J. K., Dexter, D. F., & Roder, J. (1985) · International Journal of Cancer · doi:10.1002/ijc.2910350414 · Cited by 62
Frumento, G., Franchello, S., Palmisano, G. L., Nicotra, M., Giacomini, P., Loke, Y. W., Geraghty, D. E., Maio, M., Manzo, C., Natali, P. G., et al. (2000) · Tissue Antigens · doi:10.1034/j.1399-0039.2000.560104.x · Cited by 56
Immunity to Human Papillomavirus—Associated Cervical Neoplasia
Stern, P. L. (1996) · Advances in cancer research · doi:10.1016/s0065-230x(08)60863-5 · Cited by 42
Pérez, M., Algarra, I., Ljunggren, H., Caballero, A., Mialdea, M. J., Gaforio, J. J., Klein, G. O., Kärre, K., & Garrido, F. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910460219 · Cited by 39
Self-citationAssumptions of the tumor ‘escape’ hypothesis
Restifo, N. P., Antony, P. A., Finkelstein, S. E., Leitner, W. W., Surman, D. R., Theoret, M. R., & Touloukian, C. E. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0399 · Cited by 35
Méndez, R., Serrano, A., Jäger, E., Maleno, I., Ruiz‐Cabello, F., Knuth, A. K., & Garrido, F. (2001) · Tissue Antigens · doi:10.1034/j.1399-0039.2001.057006508.x · Cited by 35
Self-citationAlgarra, I., Gaforio, J. J., Garrido, A., Mialdea, M. J., Pérez, M., & Garrido, F. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910470716 · Cited by 30
Self-citationGarrido, A., Pérez, M., Delgado, C. H., Ml, G., Rojano, J., Algarra, I., & Garrido, F. (1986) · PubMed · Cited by 30
Self-citationBoesen, M., Svane, I. M., ENGEL, A. ‐., Rygaard, J., Thomsen, A. R., & Werdelin, O. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01292.x · Cited by 24
Immunodeficiency states and related malignancies
McClain, K. L. (1997) · Cancer treatment and research · doi:10.1007/978-1-4615-5767-8_2 · Cited by 22
Cited by
Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans
Grazia Roncarolo, M., Gregori, S., Battaglia, M., Bacchetta, R., Fleischhauer, K., & Levings, M. K. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00420.x · Cited by 1,173
Immune parameters affecting the efficacy of chemotherapeutic regimens
Zitvogel, L., Kepp, O., & Kroemer, G. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.223 · Cited by 669
Tumor-Driven Evolution of Immunosuppressive Networks during Malignant Progression
Kim, R., Emi, M., Tanabe, K., & Arihiro, K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4128 · Cited by 445
Donadi, E. A., Castelli, E. C., Arnaiz-Villena, A., Roger, M., Rey, D., & Moreau, P. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0580-7 · Cited by 362
Vaccines for tumour prevention
Lollini, P.-L., Cavallo, F., Nanni, P., & Forni, G. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1815 · Cited by 340
Metadata
- Authors
- Algarra, I., Garc�a-Lora, A., Cabrera, T., Ruiz-Cabello, F., & Garrido, F.
- Venue
- Cancer Immunology, Immunotherapy
- Published
- 2004-04-07
- Volume
- 53
- Issue
- 10
- Pages
- 904-10
- ISSN
- 0340-7004 (ISSN-L)
- 1432-0851
- OpenAlex
- W2161585699
- Cited by
- 293
- References
- 57
- FWCI
- 7.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.